NASDAQ: APVOAptevo Therapeutics Inc Stock Ownership - Who owns Aptevo Therapeutics?
Insider buying vs selling
Have Aptevo Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when APVO insiders and whales buy or sell their stock.
APVO Shareholders
What type of owners hold Aptevo Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fuad Elhibri | 566.47% | 3,021,899 | $2.22M | Insider |
| Renaissance Technologies LLC | 96.87% | 516,789 | $380.36k | Institution |
| Sabby Management LLC | 65.51% | 349,471 | $257.21k | Institution |
| Citadel Advisors LLC | 49.14% | 262,124 | $192.92k | Institution |
| Scott C. Stromatt | 40.52% | 216,183 | $159.11k | Insider |
| Schonfeld Strategic Advisors LLC | 29.81% | 159,000 | $117.02k | Institution |
| Squarepoint Ops LLC | 26.00% | 138,697 | $102.08k | Institution |
| Jane A. Gross | 20.54% | 109,583 | $80.65k | Insider |
| Millennium Management LLC | 19.61% | 104,608 | $76.99k | Institution |
| Vanguard Group Inc | 17.19% | 91,725 | $67.51k | Institution |
APVO vs Biotech Stocks
Aptevo Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.